Immix Biopharma Inc — Quarterly Financial Data (NASDAQ:IMMX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Nachrichten

Immix Biopharma: FDA erteilt Sonderstatus für Therapie – Aktie legt zu

FDA erteilt Amyloidose-Medikament von ImmixBio den Status einer "Breakthrough Therapy"

Immix Biopharma stock climbs after FDA grants breakthrough therapy status

FDA grants breakthrough therapy status to ImmixBio’s amyloidosis drug

Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities - Immix Biopharma (NASDAQ:IMMX)

Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition (IMMX)

Immix Biopharma CFO Gabriel Morris buys $5k in shares

Ilya Rachman, Immix Biopharma CEO, buys $4975 in shares

Immix Biopharma stock price target raised to $12 from $8 at H.C. Wainwright

Immix Biopharma schließt Kapitalerhöhung über 93,7 Mio. US-Dollar ab

Immix Biopharma closes $93.7 million public offering

Immix Biopharma sichert sich 100 Mio. US-Dollar zur Finanzierung von Amyloidose-Medikament